Previous close | 1,790.00 |
Open | 1,788.00 |
Bid | 1,804.00 x 0 |
Ask | 1,830.00 x 0 |
Day's range | 1,770.00 - 1,827.00 |
52-week range | 1,428.50 - 1,964.00 |
Volume | |
Avg. volume | 569,190 |
Market cap | 3.309B |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | 18.79 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.77 (4.30%) |
Ex-dividend date | 30 Nov 2023 |
1y target est | N/A |
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
Johnson Matthey (JM), a global leader in sustainable technologies, has today signed an investment agreement with the Jiading District in Shanghai to help accelerate the hydrogen economy in China.
Johnson Matthey (JM), a global leader in sustainable technologies, and Hystar, a Norwegian high-tech hydrogen company, have signed a three-year strategic supply agreement to ramp up renewable (green) hydrogen production. This delivers on JM's published milestone of winning at least two strategic partnerships in Hydrogen Technologies by the end of 2022/23.